Systems and methods for laser-induced calcium disruption

JP2024500359A5Active Publication Date: 2024-12-05RES DEVMENT FOUND
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023535463
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-11
Filing Date
2021-12-10
Publication Date
2024-12-05
Estimated Expiration
2041-12-10

AI Technical Summary

Technical Problem

Current methods for addressing intravascular calcium in atherosclerosis, such as high-pressure balloon inflation, rotary atherectomy, and intravascular lithotripsy using electrodes, are ineffective in ensuring complete stent deployment and pose risks like debris introduction and myocardial infarction, while lacking spatial and temporal control over energy delivery.

Method used

Utilizing electromagnetic energy, particularly laser energy, to generate sound pressure waves within an expandable member like a balloon for precise calcium disruption, allowing real-time imaging and control over shock wave generation.

Benefits of technology

The laser-based method achieves more effective and controlled calcium disruption, increasing vascular compliance and reducing procedural risks by generating larger pressure amplitudes and providing real-time imaging feedback, suitable for treating conditions like calcified aortic stenosis and improving blood flow.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000020_0000
    Figure 00000020_0000
  • Figure 00000020_0001
    Figure 00000020_0001
  • Figure 00000020_0002
    Figure 00000020_0002
Patent Text Reader

Abstract

Apparatus, systems, and methods for disrupting calcium in an artery of a patient. Certain embodiments include an expandable member, a laser light source, and an optical fiber coupled to the laser light source. The optical fiber may include one or more emission points configured to emit electromagnetic energy from the laser light source. The electromagnetic energy may be transmitted through a fluid in the expandable member to disrupt the calcium.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Application No. 63 / 124,357, filed December 11, 2020, the entire contents of which are incorporated herein by reference. [Background technology]

[0002] Background information Coronary atherosclerosis is the most common type of cardiovascular disease, causing hundreds of thousands of deaths each year in the United States. Calcium in atherosclerosis is common in coronary artery disease (CAD) and is problematic during coronary interventions. Calcium can also reduce arterial compliance, impair cardiac output and complicate cardiovascular interventions. For example, calcium increases the complexity of the procedure by preventing the complete deployment of stents, which can lead to stent thrombosis (heart attack), which has a high mortality rate.

[0003] Current clinical solutions to increase vascular compliance and address excess calcium include high pressure balloon inflation and calcium scoring with cutting balloons. However, these approaches are often unsuccessful for a variety of reasons. Coronary atherectomy with rotational atherectomy systems (e.g., Rotablator™) and orbital atherectomy are both suitable for removing superficial luminal calcium. However, these approaches do not address deeper calcium and therefore do not always provide sufficient vascular compliance increase to ensure full deployment of the stent. These techniques are also technically complex, time consuming, and may also pose increased risks as debris from the cuts may be delivered into the microcirculation resulting in myocardial infarction during the procedure. Thus, addressing the calcium challenges of atherosclerosis in a safe and effective manner is a major clinical challenge for cardiovascular health and treatment, including placement of fully deployed stents.

[0004] Intravascular lithotripsy techniques based on kidney stone treatment have been developed using electrodes inside a balloon catheter. The electrodes vaporize the fluid in the balloon to generate acoustic pressure waves that travel through the soft tissue of the blood vessel and selectively fracture calcium in the vessel wall. The large difference in density and mechanical properties between calcium and the soft tissue allows the acoustic pressure to fracture the calcium while leaving the soft tissue intact. However, the use of electrodes limits the amount of energy available and the ability to spatially and temporally control the delivery of energy to vaporize the fluid and induce calcium fracture. Electrical approaches also result in large voltage spikes and require pacing of the heart each time an electrical pulse is delivered, which is not ideal.

[0005] Therefore, a system and method that overcomes these and other limitations associated with existing systems and methods is desirable. Summary of the Invention

[0006] overview There is an urgent need recognized for the possibility of effectively disrupting intravascular calcium to treat patient conditions including atherosclerosis and other coronary diseases, as well as a need to decalcify heart valves and aortas.

[0007] Exemplary embodiments of the present disclosure provide unique advantages over existing systems and methods. For example, it is believed that more effective treatment can be provided by utilizing electromagnetic energy (including, for example, laser energy) to generate acoustic pressure within an expandable member such as a balloon. The pressure amplitude generated by a laser is an order of magnitude greater than that generated by an electrode. In addition, laser irradiation allows flexible temporal and spatial control over shock wave generation. The advantages of pressure amplitude and temporal and spatial control can be utilized to provide greater and more efficient calcium disruption.

[0008] In addition, laser shock wave generation has the advantage of more precise spatial and temporal control of cavitation or bubble formation in the liquid contained within the balloon that generates pressure. By varying the duration of the laser pulse, unique bubble shapes with preset arrival times can also be created, which may allow for more predictable and improved calcium disruption. In addition, the laser approach allows for time generation of secondary pulses, which may provide therapeutic benefits. While existing techniques may use optical imaging to verify the effectiveness of calcium disruption after treatment, exemplary embodiments of the present disclosure can provide imaging during calcium disruption to monitor the effectiveness of calcium disruption in real time. Specific embodiments of the present disclosure may be used in the treatment of calcified aortic stenosis to decalcify the leaflets and delay the need for aortic valve replacement (AVR) or transcatheter aortic valve replacement (TAVR). The approaches described herein may also be used to create calcium fracturing in the aorta, which improves elastic recoil in various disease conditions and therefore improves blood supply to the microcirculation during diastole.

[0009] Exemplary embodiments include a device configured to disrupt coronary calcium comprising: an expandable member; a laser light source; and an optical fiber coupled to the laser light source, the optical fiber comprising one or more emission regions configured to emit electromagnetic energy from the laser light source from the optical fiber, the emission of electromagnetic energy from the one or more emission regions configured to cause spallation in the coronary calcium. In certain embodiments, the expandable member comprises a fluid, and the emission of electromagnetic energy from the emission regions is configured to cause spallation in the coronary calcium by generating ultrasound waves in the fluid. In particular embodiments, the one or more emission regions are configured as conical reliefs in the optical fiber. In some embodiments, the optical fiber is a first optical fiber; the device further comprises a plurality of optical fibers; and each optical fiber of the plurality of optical fibers comprises one or more emission regions configured to emit electromagnetic energy from each optical fiber in a radial pattern. In a specific embodiment, the expandable member is a balloon.

[0010] In certain embodiments, the expandable member is configured to be expanded via a fluid contained within the expandable member. Certain embodiments further comprise a first port configured to deliver the fluid to the expandable member. Some embodiments further comprise a second port configured to drain the fluid from the expandable member. In specific embodiments, the fluid is configured to absorb electromagnetic energy from the optical fiber and generate acoustic waves that propagate to the calcium. In certain embodiments, the fluid is a saline fluid. In certain embodiments, the optical fiber is configured to emit electromagnetic energy in a radial pattern. In some embodiments, the electromagnetic energy is emitted at a wavelength of about 2 μm. In specific embodiments, the electromagnetic energy is emitted at a wavelength between 1.5 μm and 2.5 μm. Certain embodiments further comprise an intravascular imaging device. In certain embodiments, the intravascular imaging device is an intravascular ultrasound (IVUS) device. In some embodiments, the intravascular imaging device is an optical coherence tomography imaging (OCT) device.

[0011] An exemplary embodiment includes a method of disrupting calcium in an artery, the method comprising the steps of: inserting a catheter into an artery; and emitting electromagnetic energy from the catheter, where calcium is located in the artery, the catheter comprising a laser light source and an optical fiber, fluid surrounding the optical fiber, the electromagnetic energy being generated by the laser light source, and where the electromagnetic energy absorbed in the fluid surrounding the optical fiber produces acoustic waves that enter the arterial wall and disrupt the calcium.

[0012] In certain embodiments, the catheter comprises an expandable member, and the method further comprises expanding the expandable member. In particular embodiments, the expandable member is expanded after the catheter is inserted into the artery and prior to emitting electromagnetic energy from the catheter. In some embodiments, the expandable member is expanded to conform to a surface of calcium located within the artery. In specific embodiments, the expandable member is expanded via a fluid contained within the expandable member. In certain embodiments, electromagnetic energy emitted from the catheter is absorbed by the fluid surrounding the optical fiber and propagates into the calcium. In particular embodiments, electromagnetic energy emitted from the catheter causes cavitation in the fluid contained within the expandable member. In some embodiments, the cavitation produces ultrasound waves in the fluid contained within the expandable member. In specific embodiments, the ultrasound waves produce fractures in the calcium located within the artery. In certain embodiments, the calcium comprises inhomogeneities, and the fractures are formed along the inhomogeneities in the calcium. In particular embodiments, fracturing the calcium increases the compliance of the artery. In some embodiments, the electromagnetic energy is emitted at a wavelength of about 2 μm. In specific embodiments, the electromagnetic energy is emitted at a wavelength of 1.5 μm to 2.5 μm. Certain embodiments further comprise imaging the artery during the fragmentation of the calcium, and particular embodiments further comprise imaging the artery prior to the fragmentation of the calcium.

[0013] Certain embodiments include an apparatus configured to disrupt coronary calcium, the apparatus comprising: an intravascular imaging device; an expandable member; a laser light source configured to emit electromagnetic energy; and an optical fiber coupled to the laser light source, the optical fiber having a proximal end and a distal end, and configured to emit the electromagnetic energy from the laser light source from the distal end of the optical fiber. In certain embodiments, the expandable member comprises a fluid, and the electromagnetic energy from the distal end of the fiber is configured to cause disruption in the coronary calcium by generating ultrasound waves in the fluid. In some embodiments, the expandable member is a balloon. In specific embodiments, the expandable member is configured to be stretched via a fluid contained within the expandable member. Certain embodiments further comprise a first port configured to deliver a fluid to the expandable member. Certain embodiments further comprise a second port configured to drain a fluid from the expandable member. In some embodiments, the second port is further configured to evacuate vapor bubbles from the expandable member. In specific embodiments, the fluid is configured to absorb electromagnetic energy from the optical fiber and generate and propagate acoustic waves to the calcium. In certain embodiments, the fluid is indocyanine green (ICG). In particular embodiments, the electromagnetic energy is emitted at a wavelength of 790-810 nanometers (nm). In a specific embodiment, the electromagnetic energy is emitted at a wavelength of about 793 nm.

[0014] In certain embodiments, the electromagnetic energy emitted from the optical fiber is less than 1.0 kilowatts (kW). In particular embodiments, the electromagnetic energy emitted from the optical fiber is about 0.6 kW. In some embodiments, the laser light source is a diode laser. In specific embodiments, the intravascular imaging device is an intravascular ultrasound (IVUS) device. In certain embodiments, the intravascular imaging device is an optical coherence tomography imaging (OCT) device. In particular embodiments, the intravascular imaging device has an outer diameter of less than 2.0 millimeters (mm). In some embodiments, the intravascular imaging device has an outer diameter of about 1.2 millimeters mm.

[0015] In the following disclosure, the term "coupled" is defined as connected, although not necessarily directly, and not necessarily mechanically.

[0016] The use of the word "a" or "an" when used in conjunction with the term "comprising" in the claims and / or this specification may mean "one," but is also consistent with the meaning of "one or more" or "at least one." The terms "about" and "approximately" generally mean the stated value plus or minus 5%. The use of the term "or" in the claims is used to mean "and / or," unless it is explicitly stated that only alternatives are referred to or the alternatives are mutually exclusive; however, this disclosure supports a definition that refers only to alternatives and "and / or."

[0017] The terms "comprise" (and any variation of comprise, such as "comprises" and "comprising"), "have" (and any variation of have, such as "has" and "having"), "include" (and any variation of include, such as "includes" and "including"), and "contain" (and any variation of contain, such as "contains" and "containing") are open-ended linking verbs. As a result, a method or device that "comprises," "has," "includes," or "contains" one or more steps or elements means that the method or device has one or more steps or elements, but is not limited to having only those one or more elements. Similarly, a method step or device element that "comprises," "has," "includes," or "contains" one or more features means that the method or device has one or more features, but is not limited to having only those one or more features. Furthermore, a device or structure configured in a certain manner is configured in at least that manner, but may also be configured in manners not listed.

[0018] Other objects, features, and advantages of the present invention will become apparent from the following detailed description, but it should be understood that the following detailed description and specific examples, while indicating specific embodiments of the present invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description. [Brief description of the drawings]

[0019] The following drawings form part of the present specification and are included herewith to further demonstrate certain aspects of the present disclosure. The invention may be better understood by reference to one of these drawings in combination with the detailed description of specific embodiments presented herein.

[0020] [Figure 1] 1 shows a schematic diagram of an artery with a guidewire for use with a device according to an exemplary embodiment. [Diagram 2] 1 shows a schematic diagram of an exemplary embodiment according to the present disclosure during an early stage of use. [Diagram 3] FIG. 2 shows a schematic diagram of a portion of the embodiment of FIG. 1 in use. [Figure 4] FIG. 2 shows a schematic diagram of a portion of the embodiment of FIG. 1 in use. [Diagram 5] 1 shows a schematic end view of an exemplary embodiment according to the present disclosure. [Figure 6] FIG. 6 shows a schematic diagram of a portion of the embodiment of FIG. 5 in use. [Figure 7] FIG. 6 shows a schematic diagram of a portion of the embodiment of FIG. 5 in use. [Figure 8] FIG. 6 shows a schematic diagram of a portion of the embodiment of FIG. 5 in use. [Figure 9] FIG. 6 shows a schematic diagram of a portion of the embodiment of FIG. 5 in use. [Figure 10] 1 illustrates an end view of an exemplary embodiment according to the present disclosure. [Figure 11] 11 shows an exemplary dimensional drawing of the embodiment of FIG. 10. [Figure 12] 1 shows a graph of peak pressure amplitude as a function of fluence rate for various techniques. [Figure 13] 1 shows a graph of pressure vs. volume compliance curves measured during testing of an exemplary embodiment of the present disclosure. [Figure 14] 1 shows a graph of pressure vs. volume compliance curves measured during testing of an exemplary embodiment of the present disclosure. [Figure 15] 1 shows an optical coherence tomography (OCT) image of an artery before treatment according to an exemplary embodiment of the present disclosure. [Figure 16] 1 shows an optical coherence tomography (OCT) image of an artery after treatment according to an exemplary embodiment of the present disclosure. [Figure 17] 1 shows a graph illustrating molar extinction coefficient vs. wavelength according to an exemplary embodiment of the present disclosure. [Figure 18]1 shows a graph illustrating pressure vs. Joules per pulse according to an exemplary embodiment of the present disclosure. [Figure 19] 1 shows a graph illustrating molar extinction coefficient vs. wavelength according to an exemplary embodiment of the present disclosure. [Figure 20] 1 shows a graph illustrating absorbance vs. wavelength according to an exemplary embodiment of the present disclosure. [Figure 21] 1 shows a graph illustrating nanorod optical density vs. wavelength, according to an exemplary embodiment of the present disclosure. [Figure 22] 1 shows a schematic diagram of an exemplary embodiment according to the present disclosure in use. [Figure 23] 23 shows a cross-sectional view of the embodiment of FIG. 22. [Figure 24] 23 shows a schematic diagram of one embodiment of the optical fiber of the embodiment of FIG. 22. [Diagram 25] 1 shows OCT images of an ex vivo human artery before and after a laser-guided lithotripsy procedure. [Figure 26] 1 shows images of different subjects before and after undergoing a laser-guided lithotripsy procedure. [Figure 27] 1 shows micro-CT images of an ex vivo human artery before and after laser-induced disruption. [Figure 28] 1 shows a graph of pressure vs. energy for different pulse durations in different fluids for laser-guided lithotripsy. [Figure 29] Stenosis in a rabbit model and laser-induced shock wave disruption in ex vivo human arteries are shown. [Diagram 30] 1 illustrates an embodiment of a laser light source comprising multiple diode lasers. [Diagram 31] 1 shows a graph of absorption coefficient vs. wavelength for different concentrations of indocyanine green (ICG) saline solutions. [Diagram 32] 1 shows a graph of absorption coefficient vs. wavelength for the same concentration of ICG in different solutions. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0021] DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS Exemplary embodiments of the present disclosure include devices and methods for disrupting calcium in arteries, including, for example, calcium in coronary arteries. Referring first to Figures 1-4, an overview of exemplary devices and methods of use is shown. For clarity, not all features shown in each figure are numbered in every figure. In Figure 1, a guidewire 200 is inserted into a coronary artery 250, and calcium 270 is located within the artery 250. In Figure 2, a catheter device 100 is inserted into the artery 250 over the guidewire 200. In the illustrated embodiment, the device 100 comprises an expandable member 110 (e.g., a balloon) and an optical fiber 120 coupled to a laser light source 130. In the illustrated embodiment, the optical fiber 120 comprises one or more emission points 140 configured to emit electromagnetic energy 150 (shown in Figure 3) from the laser light source 130 from the optical fiber 120 in a radial pattern. In certain embodiments, the emission points 140 may be configured as a conical relief or end of the optical fiber 120. In other embodiments, the emission point 140 may be configured as a chamfered, angled, or flat relief or end of the optical fiber 120. In the illustrated embodiment, the device 100 comprises a control system 135 configured to control the operating parameters of the device 100, including, for example, the operation of the laser source 130 (e.g., laser pulse duration, frequency, amplitude, etc.).

[0022] In the embodiment shown in Figure 3, the expandable member 110 is expanded within the artery 250 via fluid 115 (e.g., saline fluid) pressurized within the expandable member 110. In the embodiment shown, the expandable member 110 is expanded after the device 100 is inserted into the artery 250 and prior to releasing electromagnetic energy 150 from the device 100. The electromagnetic energy 150 creates cavitation 155 (e.g., gas bubbles) in the fluid 115, which generates ultrasound waves 125 from the formation and collapse of the gas bubbles 155 in the fluid 115. In certain embodiments, the expandable member 110 may be configured as a large balloon configured for treatment of the distal aorta to increase compliance of the aorta in elderly patients with resistant systolic hypertension and to increase elastic recoil during diastole to improve blood flow to the microcirculation.

[0023] 4, ultrasound waves 125 propagate through fluid 115, causing fractures 275 only in calcium 270 without damaging the vessel wall, which is more elastic than calcium plaque. In an exemplary embodiment, fractures 275 occur along inhomogeneities in calcium 270 and / or within the calcium-hard tissue-soft tissue interface. The fractures in calcium 270 increase the compliance of artery 250, allowing artery 250 to expand and contract more easily with pressure changes.

[0024] 5-11, another embodiment of the present disclosure is shown in use. This embodiment is similar to the previous embodiment, but includes multiple optical fibers. Although not shown in Figures 5-11, it will be understood that this embodiment includes components shown in Figures 1-4, such as laser source 130 and control system 135.

[0025] 5, an end view of device 100 is shown with four optical fibers 120. Although the illustrated embodiment shows four optical fibers 120, it will be understood that other embodiments may include more or less than the four optical fibers shown in this embodiment.

[0026] In FIG. 6, the device 100 is inserted into an artery 250 with calcium 270. It is understood that a guidewire (not shown) may be used to position this embodiment in a manner similar to the embodiment shown and described in FIGS. 1-4. In FIG. 7, pressurized fluid 115 stretches expandable member 110 within artery 250 to conform to the contours of artery 250 and calcium 270. In FIG. 8, a laser source (e.g., equivalent to light source 130 shown in FIG. 2) is activated such that electromagnetic energy 150 is emitted from emission point 140. As shown in FIG. 9, the electromagnetic energy 150 creates cavitations 155 (e.g., gas bubbles) in the fluid 115, which generates ultrasound waves 125 from the formation and collapse of the gas bubbles in the fluid 115.

[0027] Referring now to Figure 10, a schematic cross-sectional end view of an embodiment including additional ports as further described below is shown. Figure 10 illustrates an embodiment of a device 100 including an expandable member 110 coupled to a catheter 114 via a weld (e.g., ultrasonic weld) 112. In the illustrated embodiment, the device 110 includes fluid ports 122 and 124 configured to deliver fluid (e.g., saline fluid) to the expandable member 110, and a vent or drain port 126 configured to evacuate the fluid, such as to reduce the cross-sectional diameter and volume of the expandable member 110 prior to removal of the device from the artery. Additionally, the port 126 may be configured to vent or remove air bubbles from the expandable member 110 following delivery of electromagnetic energy 150.

[0028] The accumulation of air bubbles from the expandable element (balloon) after activation of the laser source is difficult to control and its removal is crucial: accumulation of single or multiple air bubbles from a previous laser activation can redirect (result in unfocused delivery) the electromagnetic energy during the subsequent laser shot, which can lead to complications such as damage to the vessel wall.

[0029] The illustrated embodiment also includes a port 128 configured to receive the optical fiber 120. In the illustrated embodiment, the optical fiber 120 is located within a conduit 121. In certain embodiments, the conduit 121 may be configured as a capillary, and in one specific embodiment, the conduit 121 is a Polymicro Flexible Fused Silica Capillary Tubing with an inner diameter of 200 μm and an outer diameter of 350 μm, available from Molex®. The optical fiber 120 may provide imaging of the procedure in real time (including, for example, optical coherence tomography [OCT] imaging) to provide visual feedback to the user on the extent of calcium fracturing and allow for more precise control of the device 100.

[0030] In certain embodiments, instead of or in addition to calcium fracture detection, OCT imaging can be used for other aspects.For example, in certain embodiments, OCT imaging can be used for navigation, identification and size estimation of calcium plaque to identify treatment regimen (e.g., to provide more precise treatment), and laser control.

[0031] 11 illustrates an end view with dimensions for one specific embodiment of a catheter 114 with fluid supply ports 122 and 124, a vent or drain port 126, and a port for an optical fiber 128. It is understood that other embodiments may have different dimensional configurations than the aspects shown in FIG.

[0032] The exemplary embodiments of the present disclosure provide numerous benefits and advantages through the disruption of intravascular calcium in the techniques disclosed herein. For example, the use of light (e.g., laser) energy has distinct advantages in generating suitable acoustic waves compared to the use of electricity. These advantages include a greater net energy delivered for a given form factor of the catheter device. In addition, the exemplary embodiments of the present disclosure provide more control over the laser-water interaction through pulse duration, pulse repetition rate, wavelength, and fluence / fluence rate. Furthermore, the exemplary embodiments provide beam shaping, which allows bubble formation that is conductive for a given desired acoustic wave propagation pattern. Additionally, given the price of optical fibers, the exemplary embodiments may provide for a more economical catheter. Furthermore, the use of electricity requires pacing with each pulse, whereas light does not result in cardiac pacing.

[0033] Utilizing electromagnetic (e.g., laser) energy to generate acoustic pressure within an expandable member (e.g., balloon) is believed to provide a more effective lithotripsy device for fracturing arterial calcium within the vessel wall and increasing vessel compliance. Given the extremely high energy density possible with fiber-delivered laser pulses, for a given form factor, the calculated and / or measured ultrasonic pressure is an order of magnitude greater than the pressure generated at the electrode. As illustrated in FIG. 12, peak pressure amplitude as a function of fluence rate shows that values ​​as high as 300 bar can be achieved by delivering radiation with a 200 μm fiber. In comparison, maximum pressure amplitudes reported in several studies by other investigators (e.g., Shockwave Medical Inc., Santa Clara CA) are in the range of approximately 40-50 bar. This suggests that light can be used to generate multiple shock waves in a single shot or to fracturize larger accumulations of calcium, such as calcium nodules.

[0034] The larger amplitude of the pressure waves generated during laser-induced bubble formation and collapse may promote larger and more beneficial intracalcium fractures. Triggering laser irradiation also has the advantage of allowing finer temporal control of bubble creation to generate pressure, compared to other techniques, including the use of electrode-generated current. During testing of exemplary embodiments of the present disclosure, temporal videography of laser-generated bubbles showed that laser formation was more uniform and controlled, in contrast to electrically generated bubbles; this may be due to the higher noise level in current and the complex and sometimes chaotic thermal-mechanical-electrical interactions.

[0035] While other techniques use imaging to verify post-treatment efficacy, exemplary embodiments of the present disclosure can provide real-time imaging feedback for the procedure. Such feedback is necessary to determine the laser dosimetry required to increase vascular compliance in arteries with complex calcification patterns. Exemplary embodiments of the present disclosure can combine a high-intensity light source (such as a multiphoton light source, including a two-photon light source) with imaging into a single double-clad fiber. Such a configuration illustrates well how optical coherence tomography (OCT) imaging can be incorporated into a catheter as feedback during laser lithotripsy to assess treatment efficacy. In addition, OCT can also guide treatment orientation by detecting calcium in the arterial wall, which allows the acoustic effects of laser lithotripsy to be adjusted based on calcium location and loading. In certain embodiments, OCT imaging can provide guidance not only by detecting calcified lesions or calcium plaques, but also by real-time calcium scoring with measurements of parameters such as thickness, length, and angle. Exemplary embodiments may include any of a number of options for the interaction of the laser with water. Water has absorption peaks at 1.3 μm, 1.94 μm, 2.07 μm, and 2.94 μm. Readily available lasers at these wavelengths include neodymium yttrium aluminum garnet (Nd:YAG), thulium (Tm), holmium yttrium aluminum garnet (Ho:YAG), and erbium (Er:YAG).

[0036] Referring now to FIG. 22, an overview of an exemplary apparatus and method of use is illustrated. This embodiment is similar to the previous embodiment and also includes one or more intravascular imaging devices. For clarity, not all features shown in each figure are numbered in every figure. For example, the apparatus 100 may include a laser light source, similar to the control system 135 and laser light source 130 shown in FIG. 3; and a control system configured to control the operating parameters of the apparatus 100, including, for example, the operation of the laser light source (e.g., laser pulse duration, frequency, amplitude, etc.).

[0037] In Figure 22, a guidewire 200 is inserted into a coronary artery 250, and calcium 270 is located within the artery 250. In this embodiment, a portion of the device 100 is inserted over the guidewire 200 into the artery 250. In the embodiment shown, the device 100 comprises an expandable member 110 (e.g., a balloon) and an optical fiber 120 coupled to a laser source (e.g., an equivalent of the laser source 130 in Figure 3).

[0038] The apparatus 100 also includes an intravascular imaging device 160. In the particular embodiment shown, the intravascular imaging device 160 is configured as an intravascular ultrasound (IVUS) device including an ultrasound transceiver 162 including multiple transducers 164 extending around its circumference. In certain embodiments, the transducers 164 are arranged circumferentially in one or more rows around the ultrasound transceiver 162. In exemplary embodiments, the transducers 164 may be configured to provide imaging data from the entire inner circumference of a lumen (e.g., artery 250) into which the ultrasound transceiver 162 is inserted. In specific embodiments, the ultrasound transceiver 162 may incorporate aspects of a commercially available system, such as, for example, the Eagle Eye Platinum digital intravascular ultrasound (IVUS) system available from Koninklijke Philips NV®.

[0039] The exemplary embodiment with transducers 164 extending around the circumference of the ultrasonic transceiver 162 may provide certain features not found in other embodiments, such as those incorporating a rotating array of transducers. For example, because the guidewire 200 extends through the interior of the ultrasonic transceiver 162, the guidewire 200 does not introduce artifacts because photoacoustic signals are transmitted and received from multiple points around the circumference of the transceiver 162. Thus, the guidewire 200 does not block the transmission and reception of photoacoustic signals for each of the transducers 164 extending around the circumference of the ultrasonic transceiver 162 (as opposed to a linear array of rotating transducers), and does not introduce artifacts.

[0040] Additionally, embodiments incorporating a circumferential transducer 164 can transmit and receive photoacoustic signals from multiple points around the circumference of the transceiver 162 without moving the transceiver 162. Thus, there is no need to rotate the transceiver 162 to provide imaging data about the inner circumference of the artery 250. The ability to provide circumferential imaging data without rotating the transceiver 162 allows the diameter of the device 100 to be smaller compared to embodiments that require a mechanism to rotate the imaging device. Thus, the device 100 shown in FIG. 22 can be inserted into a lumen that has a smaller diameter compared to a coronary artery, such as a peripheral artery.

[0041] In the embodiment shown in FIG. 23 (a cross-section taken along line AA in FIG. 22), the device 100 has an outer diameter of about 1.5 millimeters (mm). The transceiver 162 has an outer diameter of about 1.2 mm, the optical fiber 120 has an outer diameter of about 0.32 mm, and the guidewire 200 has an outer diameter of about 0.23 mm. Both the guidewire 200 and the optical fiber 120 extend through the transceiver 162, which is located within the 1.5 mm diameter catheter of the device 100. It is understood that the diameters disclosed herein are merely illustrative of one embodiment, and other embodiments may include components with different diameters. Although not shown for clarity, it is understood that the embodiment shown in FIGS. 22-23 may also include one or more fluid ports configured to deliver fluid to the expandable member 110, and vent or drain ports configured to evacuate fluid from the expandable member 110, similar to those in the previously described embodiments.

[0042] In the embodiment shown in Figure 22, the expandable member 110 is expanded within the artery 250 via a fluid 115 pressurized within the expandable member 110. In certain embodiments of the present disclosure, the fluid 115 may be saline or may be indocyanine green (ICG), which is an FDA approved solution and provides an absorption coefficient greater than five times that of saline. It is understood that other embodiments disclosed herein may also include saline or ICG.

[0043] In this embodiment, the optical fiber 120 extends through the transceiver 162 to the interior of the expandable member 110. In operation, the optical fiber 120 may transmit electromagnetic energy 150 from the distal end 129. In certain embodiments, the distal end 129 is configured to transmit electromagnetic energy 150 in a particular direction toward the artery 250. For example, the distal end 129 may be configured (e.g., beveled, tapered, faceted, or angled) to provide directional transmission of the electromagnetic energy 150. A user can direct or target the electromagnetic energy 150 toward the calcium 270 by utilizing the intravascular imaging device 160 to determine the location of the calcium 270 within the artery 250. In certain embodiments, the electromagnetic energy 150 is provided by a diode laser (793 nm, 0.6 kW, available from DILAS Coherent® Inc.). A wavelength of 793 nm is suitable for an expandable member filled with ICG fluid, which provides strong optical absorption in the range of 790-810 nm.

[0044] As previously discussed, the electromagnetic energy 150 creates cavitations 155 (e.g., gas bubbles) in the fluid 115, which generate ultrasound waves 125 from the formation and collapse of the gas bubbles 155 in the fluid 115. By directing the electromagnetic energy 150 toward the calcium 270, the cavitations 155 and ultrasound waves 125 are also directed toward the calcium 270 and not toward portions of the artery 250 that do not have calcium 270 deposits. Thus, portions of the artery 250 that do not contain calcium 270 deposits are not subjected to the forces associated with the cavitations 155 and ultrasound waves 125 and are therefore less likely to be damaged by such forces. Because the calcium deposits 270 are not uniformly distributed, being able to obtain imaging data of the blood vessel 250 to determine the location of the calcium 270 and target the electromagnetic energy 150 to such locations may result in increased safety and reduced risk for the patient.

[0045] Certain embodiments may also incorporate other mechanisms for acquiring imaging data within the artery 250. For example, with reference to FIG. 24 , in certain embodiments, the optical fiber 120 may be configured as a double-clad fiber (e.g., DCF13 fiber available from Thorlabs© Inc.) with a gradient index (GRIN) lens 127 coupled to the distal end 129. In such embodiments, the GRIN lens 127 may be used to acquire optical coherence tomography (OCT) image data beyond the distal end 129.

[0046] 30, an embodiment of a laser source 130 is shown that includes a power source 131 electrically coupled to a plurality of diode lasers 132. In the embodiment shown, the diode lasers 132 are coupled to the optical fiber 120 via a fiber combiner 133 and an optical fiber 134. In certain embodiments, the diode laser 132 may be a 793 nm or 808 nm laser emitting 100 watts that emits electromagnetic energy at a wavelength close to the maximum absorption coefficient for a specified concentration of an ICG formulation within a stretchable member (not shown in FIG. 30) coupled to the optical fiber 120. In certain embodiments, the optical fiber 134 may be a 105 μm or 125 μm silica core fiber, and the optical fiber 134 may be a biocompatible 250 μm fiber.

[0047] This embodiment can provide higher levels of electromagnetic pulse energy coupled to the absorbent fluid medium at a lower cost by combining multiple diode lasers with a single power source and fiber combiner. In a particular embodiment, 19 diode lasers may be coupled to a single power source, although other embodiments may include a different number of diode lasers. The use of diode lasers also allows for a compact configuration and flexible pulse profiles. Thus, embodiments utilizing multiple diode lasers can provide sufficient electromagnetic energy to the absorbent biocompatible fluid within the expandable member to effectively break down calcium.

[0048] In addition, the absorbent biocompatible fluid within the expandable member may be configured to efficiently break down calcium with respect to the provided electromagnetic energy. As the molar concentration of ICG in solution increases, the absorption coefficient also increases. However, this increase is not linear. Thus, a concentration of 1x will result in a 1 cm -1 Even so, 100x does not necessarily mean 100 cm -1 No. This is due to the "aggregation" effect of the cyanine dyes. Cyanine dyes, including ICG, tend to aggregate at high concentrations in aqueous solution, which can reduce the absorption coefficient.

[0049] Less aggregation means less power is required to generate the same pressure. Dimethylsulfoxide (DMSO) can be used to avoid aggregation in ex vivo applications, but is not biocompatible. Therefore, in exemplary embodiments of the present disclosure, other techniques may be included, such as dissolving the cyanine dye in liposome-type nanodroplets. In addition, in exemplary embodiments of the present disclosure, plasma or albumin may be utilized in place of water in the solution to increase the absorption coefficient.

[0050] Referring now to FIG. 31, the absorption coefficient of ICG versus wavelength is shown for different concentrations of ICG in saline solution. ICG has an absorption coefficient of >256 cm at 808 nm. -1 , resulting in a 5x reduction in peak power requirements (eg, 5x reduction in cost) with reduced agglomeration.

[0051] The absorption coefficient of ICG is also affected by the solution in which it is diluted. Referring to FIG. 32, the absorption coefficient versus wavelength is shown for the same concentration of ICG in different solutions. As shown in FIG. 32, albumin yielded the highest absorption coefficient and water the lowest. The excimer wavelength of 308 nm is approximately 100 cm in serum albumin. -1ICG mixed in albumin has a higher absorption coefficient, and iodine contrast agents (such as those mixed with saline for fluoroscopy or angiography; e.g., OmniPaque™ (iohexol), ioversol, etc.) have an absorption coefficient of about 400-500 cm in a 50 / 50 percent mix. -1 It is.

[0052] Pure or 100% contrast agents have a wavelength of 900-1000 cm -1 Although 100% contrast is sticky and highly viscous in small lumen, it is difficult to flow the contrast into small lumen to fill an intravascular balloon. However, when the contrast is mixed 50 / 50 percent with water or saline, it flows more easily. This mixture provides an easy flow to fill the balloon and creates the shock wave generation necessary to break up the calcium. In addition, it is found that when the contrast is mixed with blood or hemoglobin, the pressure from the shock wave is higher while keeping the flow to fill the intravascular balloon constant.

[0053] In summary, tests have shown that an expandable member (e.g., a balloon) filled with 100 percent contrast agent can achieve a pressure of approximately 50 bar at an excimer wavelength of 308 nm. A mixture of blood / hemoglobin in the balloon and an excimer wavelength of 308 nm can also reach a pressure of 50 bar. Thus, by utilizing contrast agent in a balloon and illuminating the solution with an excimer wavelength of 308 nm, sufficient pressure amplitudes can be achieved to cause calcium fracturing.

[0054] In summary, tests have shown that an expandable member (e.g., a balloon) filled with 100 percent contrast agent can achieve a pressure of approximately 50 bar at an excimer wavelength of 308 nm. A mixture of blood / hemoglobin within the balloon and an excimer wavelength of 308 nm can also reach a pressure of 50 bar. Thus, by utilizing contrast agent within the balloon and illuminating the solution with an excimer wavelength of 308 nm, sufficient pressure can be achieved to cause calcium fracturing. EXAMPLES

[0055] result Figures 13-16 illustrate the results of the tests described in more detail below. For this test, a Ho:YAG laser with a wavelength of 2.07 μm was selected with a pulse duration of approximately 150 ms. Given what is known about laser-water interactions, it appears that the best choice for laser dosimetry would be with a laser module with shorter pulse duration (ns), higher water absorption, and higher energy density. This suggests Er:YAG (2.94 um, higher water absorption coefficient). Er:YAG delivery fibers, like germanium, are not biocompatible for implementation in one of these catheters. The best choice would then be a thulium (1.94 um) laser with nanosecond pulse duration capable of delivering pulsed laser energy of 1 uJ to 5 J. However, given the relative availability of higher energy laser pulses at this wavelength, the closest choice, Ho:YAG, was utilized for this test.

[0056] To test the ability of the laser to generate calciclastic pressure waves, preliminary studies were performed in fresh specimens of calcified human coronary arteries, n = 9. Arterial compliance was measured before and after holmium laser treatment, along with OCT imaging and histology.

[0057] Hearts were received from South Texas Blood and Tissue. Uptake criteria for the hearts were history of CAD or factors indicative of CAD and calcium burden, i.e., older age, overweight, hypertension, history of bypass surgery, and diabetes. The coronary arteries were isolated from the hearts. The left anterior descending artery (LAD), right coronary artery (RCA), and left circumflex artery (LCX) were all imaged with OCT. OCT was used to identify calcium within the vessels. The location of calcium was marked with a dye on the outside of the vessels so that compliance testing and laser treatment could be targeted to the same areas where calcium is present.

[0058] After identifying the location, the vessel compliance was measured. The balloon catheter was selected based on the vessel size. The vessel compliance curve was obtained by inflating the balloon with a manual balloon catheter pump (Endoflator®) and recording the balloon pressure at a given volume of added saline. This curve was repeated three times for each of the four conditions: in air before and after other tests; in the vessel before and after laser treatment; to measure the baseline compliance of the balloon and to ensure that there was no variation during the experiment due to balloon fatigue. The balloon location in the vessel was determined by the calcium location indicated by the dye.

[0059] Two holmium lasers were available for this study: MOSES™ Pulse 120H (Lumenis®, Yokneam Israel) and Coherent Holmium:YAG (Lumenis®, Yokneam Israel). These provided the energy source for the treatment through a cone-tipped optical fiber. Various pulse numbers and patterns were tested with both lasers to determine the optimal treatment option. These lasers differ by a factor of 10 in the amount of pulse energy they can deliver. An aiming beam on the laser allowed the treatment to be directed to the dye-marked area. After laser treatment, a second vessel compliance measurement and follow-up OCT image were recorded. This second OCT image was then aligned with the pre-study OCT image. The OCT images were analyzed for visible signs of calcium spallation; and changes in luminal area could be calculated for quantitative characterization. The delta of the compliance curve or increase in compliance before and after laser treatment was the endpoint measure for procedural success.

[0060] Nine coronary arteries from four human hearts were tested. In each coronary artery, arterial compliance increased after laser treatment, leading to successful procedures. Figures 13 and 14 show graphs of the recorded arterial compliance curves. The post-laser compliance (square markers) shows an improvement over the pre-laser compliance (round markers), while still being higher than the bare balloon compliance (solid line). If the post-laser compliance were the same as the balloon in air, the coronary artery would have an extremely high compliance, suggesting possible damage to the arterial wall.

[0061] 15 and 16 are optical coherence tomography (OCT) images of an artery containing calcium before (FIG. 15) and after (FIG. 16) treatment via the methods disclosed herein. As indicated by the white arrows in FIG. 15, the calcium in the artery has been disrupted after treatment.

[0062] 17 and 18, data from one exemplary embodiment is shown for absorption by indocyanine green (ICG) with a laser source emitting radiation in the wavelength range of 700-850 nm. In this embodiment, ICG has an absorption spectrum from 700-850 nm, with the absorption peak being tunable by ICG concentration measured in micromolar units (see, e.g., https: / / omlc.org / spectra / icg / ). For example, at 2.2 mg / mL (maximum concentration in liquid form, 2830 uM), the absorption coefficient can be as high as 240 cm^-1 at 755 nm and 311 cm^-1 at 700 nm. This is a significantly higher value at the absorption wavelengths for the Holmium laser compared to saline / water (e.g., for comparison, the local maximum of 119.83 cm^-1 at the water absorption peak of the Tm laser at 1940 nm and approximately 30 cm^-1 at the Holmium laser at 2.09-2.10 um).

[0063] The use of alternative fluids (instead of saline) for laser shock wave generation allows existing lasers to be used around 755 nm, including, for example, Picosure (755 nm, 900 ps, ​​200 mJ, from Cynosure); GentleLase (755 nm, >1 ms, 25 J, from Candela); Alexandrite (750 nm, 5-10 ns, 150 mJ); Laser Diode (793 nm, power 1600W, pulse duration: 100 ns-100 us, 500 us-CW, other options: 808 nm, 1600W).

[0064] The recorded shock wave pressure amplitude was as high as 1000 psi (200 mJ, 900 ps). Figure 18 provides a graph of pressure versus energy per pulse generated with ICG (~2.2 mg / mL) by a Cynosure Picosure laser (755 nm, 900 ps).

[0065] Referring now to FIG. 19, data from another embodiment was obtained using a laser source in the wavelength range of 500-600 nm with a blood / Hb fluid solution contained within a balloon. Blood has an absorption peak at 532 nm with an intensity of about 250 cm-1. The absorption of blood at 532 nm is many times higher than the absorption of water (about 30 cm^-1) at the emission wavelength of the Holmium laser. Candidates for the fluid to fill the balloon to generate the pressure required to fracture calcium within the vessel wall could be biocompatible hemoglobin or whole blood from the same patient.

[0066] Figures 20 and 21 show data from an embodiment with a biocompatible nanoparticle solution inside the balloon. In this embodiment, gold nanorods provide a tunable absorption spectrum. For example, nanorods produced by NanocomposiX and other manufacturers have an absorption peak at 980 nm (up to 100 optical density [OD], 230 cm^-1). There are also many suppliers of 980 nm diode lasers (delivering up to 570 W in a 100 um silica fiber). Other biocompatible nanorods / nanoparticles can be manufactured and may be selected depending on the availability of laser sources (808 nm, 793 nm, 980 nm, 976 nm, 1210 nm, etc.) and corresponding fiber optic delivery options.

[0067] It is also noted that albumin (human serum albumin), when mixed with ICG or by itself, has strong absorption at wavelengths in the ultraviolet (UV) spectrum. In certain embodiments, a UV laser (e.g., xenon monochloride [XeCL]) excimer, or other UV laser diode, may be utilized to generate shock waves within these albumin-filled balloons or albumin and ICG-filled balloons to disrupt calcium within the vessel walls.

[0068] 25, an OCT image of an ex vivo human artery prior to undergoing a laser-guided lithotripsy procedure in accordance with the present disclosure is shown in Panel A. Panel B of FIG. 25 shows an OCT image of that artery after laser-guided lithotripsy has been performed. As shown in Panel B, fractures have formed in the calcium, causing the cross-sectional area of ​​the artery to increase (from 3.45 mm before laser-guided lithotripsy) 2 from) 5.48 mm 2 increased to.

[0069] Panels C and D of FIG. 26 show images of Ultracal® 30 stones before and after, respectively, demonstrated with a flat 230 um core fiber under IVUS guidance according to the present disclosure. Panels E and F of FIG. 26 show IVUS images before and after laser-induced lithotripsy fragmentation in a calcified coronary artery phantom (fractures are indicated by arrows in panels D and F). Panels G and H of FIG. 27 show before and after micro-CT images of an ex vivo human artery demonstrating laser-induced fragmentation (fractures are indicated by arrows in panel H). FIG. 28 shows a graph of energy (Joules) versus pressure (bars) for different pulse durations in ICG (circles) and saline (squares); delivered in the fiber at pulse durations of 0.9 ns and 70 us. Scale bar is 1 mm.

[0070] Panels A-D of Figure 29 show fluoroscopy of the in vivo rabbit model showing various levels of stenosis from 25 percent to 100 percent. Panel E of Figure 29 shows hematoxylin and eosin (H&E) and von Kossa staining of the model artery at 4x magnification in the top and bottom rows, respectively. The brown areas in the von Kossa staining are calcium. Panels F and G of Figure 29 show laser-induced shock wave disruption in an ex vivo human artery (black arrow in panel G) compared to a control (shown in panel F); scale bars are 1 mm.

[0071] All of the devices, systems, and / or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. Although the devices, systems, and methods of the present invention have been described in terms of specific embodiments, it will be apparent to those skilled in the art that variations may be applied in the devices, systems, and / or method steps or in the sequence of method steps described herein without departing from the concept, spirit, and scope of the invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope, and concept of the invention as defined by the appended claims.

[0072] References The contents of the following references are incorporated herein by reference: TIFF2024500359000001.tif180151

Claims

1. An extensible member; A laser light source; an optical fiber coupled to the laser light source, one or more emission regions configured to emit electromagnetic energy from the laser light source out of the optical fiber; and an optical fiber configured such that emission of electromagnetic energy from the one or more emission regions causes spallation in coronary calcium; 16. An apparatus configured to disrupt coronary blood vessel calcium, comprising:

2. the expandable member comprises a fluid; and The emission of electromagnetic energy from the emission region is configured to cause spallation in the coronary calcium by generating ultrasound waves in the fluid.

2. The apparatus of claim 1.

3. 10. The device of claim 1, wherein the one or more emission regions are configured as a conical relief in an optical fiber.

4. the optical fiber is a first optical fiber; the apparatus further comprises a plurality of optical fibers; and each optical fiber of the plurality of optical fibers comprising one or more emission regions configured to emit electromagnetic energy from each optical fiber in a radial pattern; 10. Apparatus according to any one of the preceding claims.

5. 20. The device of claim 1, wherein the expandable member is a balloon.

6. 20. The apparatus of claim 1, wherein the expandable member is configured to be expanded via a fluid contained within the expandable member.

7. 7. The device of claim 6, further comprising a first port configured to deliver a fluid to the expandable member.

8. 8. The device of claim 7, further comprising a second port configured to drain fluid from the expandable member.

9. The apparatus of claim 7 , wherein the second port is further configured to vent vapor bubbles from the expandable member.

10. 9. The device of any one of claims 6-8, wherein the fluid is configured to absorb electromagnetic energy from the optical fiber, generate acoustic waves, and propagate to the calcium.

11. The device of any one of claims 6 to 10, wherein the fluid is a saline fluid.

12. 20. The apparatus of claim 1, wherein the optical fiber is configured to emit electromagnetic energy in a radial pattern.

13. 10. The device of claim 9, wherein the electromagnetic energy is emitted at a wavelength of about 2 μm.

14. 10. The device of claim 9, wherein the electromagnetic energy is emitted at a wavelength between 1.5 μm and 2.5 μm.

15. 10. The apparatus of claim 1, further comprising an intravascular imaging device.

16. 16. The apparatus of claim 15, wherein the intravascular imaging device is an intravascular ultrasound (IVUS) device.

17. 16. The apparatus of claim 15, wherein the intravascular imaging device is an optical coherence tomography imaging (OCT) device.

18. an intravascular imaging device; An extensible member; a laser light source configured to emit electromagnetic energy; an optical fiber coupled to the laser light source, a proximal end and a distal end; and an optical fiber configured to emit electromagnetic energy from the laser light source from the distal end of the optical fiber; 16. An apparatus configured to disrupt coronary blood vessel calcium, comprising:

19. the expandable member comprises a fluid; and Electromagnetic energy from the distal end of the fiber is configured to generate ultrasound waves in the fluid, thereby causing spallation in the coronary calcium.

20. The apparatus of claim 18.

20. 20. The device of claim 18 or 19, wherein the expandable member is a balloon.

21. 21. The apparatus of any one of claims 18 to 20, wherein the expandable member is configured to be expanded via a fluid contained within the expandable member.

22. 22. The device of claim 21, further comprising a first port configured to deliver a fluid to the expandable member.

23. 23. The device of claim 22, further comprising a second port configured to drain fluid from the expandable member.

24. 24. The apparatus of claim 23, wherein the second port is further configured to vent vapor bubbles from the expandable member.

25. 25. The device of any one of claims 21-24, wherein the fluid is configured to absorb electromagnetic energy from the optical fiber, generate acoustic waves, and propagate to the calcium.

26. 25. The device of any one of claims 21 to 24, wherein the fluid is indocyanine green (ICG).

27. 27. The device of any one of claims 18 to 26, wherein the electromagnetic energy is emitted at a wavelength of 790 to 810 nanometers (nm).

28. 27. The device of any one of claims 18 to 26, wherein the electromagnetic energy is emitted at a wavelength of about 793 nm.

29. 29. The device of any one of claims 18 to 28, wherein the electromagnetic energy emitted from the optical fiber is less than 1.0 kilowatts (kW).

30. 30. The apparatus of any one of claims 18 to 29, wherein the electromagnetic energy emitted from the optical fiber is about 0.6 kW.

31. The apparatus of any one of claims 18 to 30, wherein the laser light source is a diode laser.

32. The apparatus of any one of claims 18 to 31, wherein the intravascular imaging device is an intravascular ultrasound (IVUS) device.

33. The apparatus of any one of claims 18 to 31, wherein the intravascular imaging device is an optical coherence tomography imaging (OCT) device.

34. The apparatus of any one of claims 18 to 33, wherein the intravascular imaging device has an outer diameter of less than 2.0 millimeters (mm).

35. The apparatus of any one of claims 18 to 34, wherein the intravascular imaging device has an outer diameter of about 1.2 millimeters (mm).